continued HCV infection / CHC / disease / portal fibrosis / cirrhosis / hepatitis C / HCV / lhagan2@emory.edu Abbreviations CHC / post-SVR fibrosis / advanced fibrosis / AIDS / early stage fibrosis / infection / end-stage liver disease / infections / US hepatitis C / anemia / fibrosis / HCV genotype / /
Organization
National Institute of Health / Emory University School of Medicine / Food and Drug Administration / 2Johns Hopkins University School of Medicine / Veterans Affairs Medical Center / American Association for the Study of Liver Diseases / Department of Veterans Affairs / Infectious Diseases Society of America / Center for AIDS Research / US Department of Veterans Affairs National Acquisition Center / /
Person
Raymond F. Schinazi / Mark S. Sulkowski / Liesl M. Hagan / / /
HEP[removed]Revised Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 HCV in interferon ineligible/intolerant individuals Liesl M. Hagan1, Mark S. Sulkowski2, Raymond F. Schinazi1